Skip to content
Clinical Trials – home

Dipyridamole: An Overview for Patients

4 / 4
trials open to patients / all trials
7+
Countries

In short

This article explores the use of dipyridamole, also known by brand names like Persantine and Permole, in various clinical trials. Dipyridamole is being studied for its potential benefits in conditions such as HIV, cardiovascular diseases, and even schizophrenia. The drug works by increasing adenosine levels in the body, which may have protective effects against ischemia-reperfusion injury and inflammation. Through these trials, researchers aim to better understand dipyridamole's mechanisms of action and its potential to improve patient outcomes in different medical scenarios.

At a glance

Main Uses in Trials
HIV-related inflammation, cardiovascular protection, ischemia-reperfusion injury prevention, schizophrenia symptoms
Mechanism of Action
Increases adenosine levels by inhibiting nucleoside transporters
Administration Methods
Oral tablets (e.g., 200mg twice daily), intravenous injection
Common Outcome Measures
Biomarkers of inflammation, heart damage indicators (e.g., troponin), coronary blood flow, psychiatric symptom scales
Potential Side Effects
Headache, dizziness, gastrointestinal symptoms, changes in blood pressure or heart rhythm
Notable Trial Designs
Placebo-controlled, crossover studies, combination with other drugs (e.g., adenosine)
Patient Populations
HIV patients, cardiovascular disease patients, healthy volunteers, schizophrenia patients

Introduction

Dipyridamole is a medication that has been used for various cardiovascular conditions. It is also known by the brand names Persantine® and Permole®. This article will provide an overview of dipyridamole, its uses, how it works, and current research being conducted with this drug.

Medical Uses

Dipyridamole is primarily used for the following conditions:

  • Prevention of blood clots: It is used with other drugs to reduce the risk of blood clots after heart valve replacement.
  • Coronary artery disease: It may be used in patients with coronary artery disease, a condition where the arteries supplying blood to the heart become narrowed or blocked.
  • Stress tests: Dipyridamole is sometimes used during cardiac stress tests to evaluate heart function.

How It Works

Dipyridamole works in several ways:

  • It increases the levels of a substance called adenosine in the body. Adenosine helps to widen blood vessels and improve blood flow.
  • It prevents platelets (small blood cells involved in clotting) from sticking together, which helps to prevent blood clots.
  • It may have anti-inflammatory effects and could potentially protect against damage caused when blood flow is restored to tissues after a period without oxygen (known as ischemia-reperfusion injury).

Administration

Dipyridamole can be administered in different ways:

  • Oral tablets: Often given as 200mg twice daily.
  • Intravenous (IV) injection: Used in certain medical procedures or tests.

The specific dosage and method of administration will depend on the condition being treated and will be determined by a healthcare provider.

Current Research

Several clinical trials are exploring new potential uses for dipyridamole:

  • HIV treatment: Researchers are studying whether dipyridamole can reduce inflammation in HIV-infected individuals who are already on antiretroviral treatment.
  • Heart surgery: Studies are investigating if dipyridamole can protect the heart from damage during coronary artery bypass grafting (CABG) surgery.
  • Ischemia-reperfusion injury: Research is being conducted to see if dipyridamole can protect against damage caused when blood flow returns to tissues after a period without oxygen.

Potential Side Effects

Like all medications, dipyridamole can cause side effects. Some potential side effects include:

  • Headache, especially during the first few days of treatment
  • Dizziness
  • Nausea
  • Flushing (redness of the skin)

It's important to discuss any side effects with your healthcare provider.

Frequently Asked Questions

What is dipyridamole used for?

Dipyridamole is primarily used to prevent blood clots, especially in patients who have had heart valve replacement. It's also used in some heart tests and is being studied for potential use in other conditions like HIV and protecting the heart during surgery.

How does dipyridamole work?

Dipyridamole works by increasing levels of a substance called adenosine in the body, which helps widen blood vessels and improve blood flow. It also prevents platelets from sticking together, which helps prevent blood clots.

Are there any side effects of dipyridamole?

Common side effects can include headache, especially when first starting the medication, as well as dizziness, nausea, and flushing. Always discuss any side effects with your healthcare provider.

Summary

AspectDetails
Primary UsesPrevent blood clots, used in coronary artery disease
How It WorksIncreases adenosine levels, prevents platelet aggregation
AdministrationOral tablets or intravenous injection
Current ResearchHIV treatment, heart surgery protection, ischemia-reperfusion injury
Common Side EffectsHeadache, dizziness, nausea, flushing

Glossary

  • Adenosine - A naturally occurring substance in the body that helps regulate blood flow and heart function
  • Antiretroviral treatment - Medications used to treat HIV infection
  • Coronary artery bypass grafting (CABG) - A type of heart surgery used to improve blood flow to the heart
  • Ischemia-reperfusion injury - Damage that occurs when blood supply returns to tissue after a period of lack of oxygen
  • Platelets - Small blood cells that help form clots to stop bleeding

Questions people often ask

Conditions where Dipyridamole is being studied

Each condition opens its own overview and trial list

Trials with Dipyridamole

Recruiting trials first

See all 4 →
Quick filters
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).